Special Issue "RNAi-Based Therapeutics"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (30 December 2012)

Special Issue Editor

Guest Editor
Prof. Dr. John J. Rossi
Department of Molecular and Cellular Biology, Irell and Manella Graduate School of Biological Sciences, Beckman Research Int. of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA
E-Mail: jrossi@coh.org
Interests: siRNA; shRNA; RNAi; aptamers; small RNA gene activators; silencers

Published Papers (12 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-12
p. 881-914
by , , , , , ,  and
Pharmaceuticals 2013, 6(7), 881-914; doi:10.3390/ph6070881
Received: 29 March 2013; in revised form: 15 June 2013 / Accepted: 11 July 2013 / Published: 19 July 2013
Show/Hide Abstract | PDF Full-text (971 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 659-680
by  and
Pharmaceuticals 2013, 6(5), 659-680; doi:10.3390/ph6050659
Received: 28 March 2013; in revised form: 10 April 2013 / Accepted: 24 April 2013 / Published: 29 April 2013
Show/Hide Abstract | Cited by 6 | PDF Full-text (693 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
abstract graphic
p. 522-535
by
Pharmaceuticals 2013, 6(4), 522-535; doi:10.3390/ph6040522
Received: 27 December 2012; in revised form: 28 March 2013 / Accepted: 2 April 2013 / Published: 11 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (270 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 510-521
by , ,  and
Pharmaceuticals 2013, 6(4), 510-521; doi:10.3390/ph6040510
Received: 31 December 2012; in revised form: 19 March 2013 / Accepted: 27 March 2013 / Published: 10 April 2013
Show/Hide Abstract | PDF Full-text (622 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 440-468
by , ,  and
Pharmaceuticals 2013, 6(4), 440-468; doi:10.3390/ph6040440
Received: 24 January 2013; in revised form: 27 February 2013 / Accepted: 13 March 2013 / Published: 25 March 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (679 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 295-319
by , , , ,  and
Pharmaceuticals 2013, 6(3), 295-319; doi:10.3390/ph6030295
Received: 11 January 2013; in revised form: 9 February 2013 / Accepted: 1 March 2013 / Published: 14 March 2013
Show/Hide Abstract | Cited by 6 | PDF Full-text (1085 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 287-294
by  and
Pharmaceuticals 2013, 6(3), 287-294; doi:10.3390/ph6030287
Received: 31 December 2012; in revised form: 18 February 2013 / Accepted: 27 February 2013 / Published: 5 March 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (127 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 223-250
by , ,  and
Pharmaceuticals 2013, 6(2), 223-250; doi:10.3390/ph6020223
Received: 19 December 2012; in revised form: 19 January 2013 / Accepted: 1 February 2013 / Published: 6 February 2013
Show/Hide Abstract | Cited by 6 | PDF Full-text (1276 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 124-160
by , ,  and
Pharmaceuticals 2013, 6(2), 124-160; doi:10.3390/ph6020124
Received: 20 December 2012; in revised form: 10 January 2013 / Accepted: 22 January 2013 / Published: 28 January 2013
Show/Hide Abstract | PDF Full-text (594 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 85-107
by , ,  and
Pharmaceuticals 2013, 6(1), 85-107; doi:10.3390/ph6010085
Received: 21 December 2012; in revised form: 8 January 2013 / Accepted: 14 January 2013 / Published: 16 January 2013
Show/Hide Abstract | Cited by 22 | PDF Full-text (222 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 61-78
by ,  and
Pharmaceuticals 2012, 5(1), 61-78; doi:10.3390/ph5010061
Received: 31 October 2011; in revised form: 20 December 2011 / Accepted: 21 December 2011 / Published: 30 December 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (572 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
abstract graphic
p. 1591-1606
by , ,  and
Pharmaceuticals 2011, 4(12), 1591-1606; doi:10.3390/ph4121591
Received: 16 September 2011; in revised form: 8 December 2011 / Accepted: 9 December 2011 / Published: 16 December 2011
Show/Hide Abstract | Cited by 3 | PDF Full-text (337 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
Select/unselect all
Displaying article 1-12
Select articles Export citation of selected articles as:

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert